Revenue rose 35% to $177.3M compared with $131.3M. This was 6% better than estimates. Operating income was $60.7M, up 35%. Net income was $18.3M, compared with a loss last year of $178.6M (non cash due to preferred share conversion last year). Cash flow fell 58% to $18.8M. EPS of 7c missed estimates of 13c. Organic growth was negative 9%. As usual there was very little commentary/forecast. It was another quarter of weak organic growth, and we need to see this stabilize. Acquisitions (not discussed by the company) are helping revenue growth but we need to see cash flow improve here as well. We will for now give the company the benefit of the doubt as we do like its strategy. Analysts expect at least 40%+ EPS earnings growth next year, and the stock has done well since its listing, though only up 14% this year (71% over one year). We would like to see how shares react to this on Monday. We would not panic here but an improvement is needed. HOLD.